TIAA CREF INVESTMENT MANAGEMENT LLC - INNOVATE BIOPHARMACEUTICLS I ownership

Back to all holdings Add to watchlist

INNOVATE BIOPHARMACEUTICLS I's ticker is INNT and the CUSIP is 45782F105. A total of 40 filers reported holding INNOVATE BIOPHARMACEUTICLS I in Q1 2019. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of INNOVATE BIOPHARMACEUTICLS I
ValueSharesWeighting
Q1 2019$54,000
-10.0%
28,022
+8.1%
0.00%–
Q4 2018$60,000
-83.1%
25,920
-50.0%
0.00%–
Q3 2018$354,000
-70.2%
51,840
+2.9%
0.00%
-100.0%
Q2 2018$1,187,000–50,374–0.00%–
 Download
Other shareholders
INNOVATE BIOPHARMACEUTICLS I shareholders Q1 2019
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of INNOVATE BIOPHARMACEUTICLS I shareholders